Safety and tolerability of fingolimod in patients with relapsing-remitting multiple sclerosis: results of an open-label clinical trial in Italy.

Alice LaroniDavide BrogiVincenzo Brescia MorraLeonello GuidiCarlo PozzilliGiancarlo ComiAlessandra LugaresiRenato TurriniDebora RaimondiAntonio UccelliGiovanni Luigi Mancardi

Published in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2016)

EudraCT 2011-000770-60.

Keyphrases

multiple sclerosis
clinical trial
open label
double blind
phase ii
white matter
phase iii
placebo controlled
randomized controlled trial
systemic lupus erythematosus